Topaz Pharmaceuticals is a start-up company that plans to develop and market pediatric medicines. The company has identified a significant unmet need for pediatrically oriented pharmaceuticals and vaccines beginning with a product to treat the pervasive issue of head lice in children aged 0 – 13.
Topaz Pharmaceuticals was acquired by Sanofi-Pasteur in 2012.